Testing gene editing techniques in pigs for biomedical research
Coordination: Swine Somatic Cell Gene Editing Testing Center
This study is working on using gene editing in pigs to create better models for understanding human diseases and finding new treatments, and it involves teamwork among researchers and regulators to ensure everything is done safely and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10928243 on NIH RePORTER |
What this research studies
This research focuses on coordinating efforts to test somatic cell gene editing techniques in swine, which are important for developing new biomedical models. The project involves managing communication and logistics among various stakeholders, including researchers and regulatory agencies. By refining standard operating procedures and providing testing services, the research aims to assess the safety and efficacy of gene editing reagents in health and disease models. The ultimate goal is to create novel swine models that can help in understanding human diseases and developing new treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include those involved in biomedical research and gene editing technologies.
Not a fit: Patients who are not involved in biomedical research or do not have a direct interest in gene editing technologies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved biomedical models that enhance our understanding of human diseases and the development of new therapies.
How similar studies have performed: Other research has shown success with similar gene editing approaches in animal models, indicating potential for this project to yield valuable insights.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Wells, Kevin Dale — University of Missouri-Columbia
- Study coordinator: Wells, Kevin Dale
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.